My Malignant Melanoma

Seanty's experiences with Metastatic Malignant Melanoma. Part of Email us direct at

Saturday, 26 March 2011


Dr. Julian Lieb flips out again

I think my latest email from psychiatrist-turned-amateur-oncologist Julian Lieb speaks for itself:

Claude Bernard noted that people whose “minds are bound and cramped” disdain opposing theories because they do not want to discover anything that might disprove their own. Bernard referred to them as “despisers of their fellows,” corrupting results that support their rivals, thus falsifying the facts.

It is the human and ethical right of every patient, physician and citizen, to receive medical information without any interference, second guessing, reevaluation, modification, editorializing, corruption, or delay. Your disparaging comments are immediately encountered upon Googling, thus corrupting my entire research output, and corrupting human and ethical rights on a gigantic scale. You have permanently damaged my reputation, and deprived an incalculable number of cancer sufferers, of their human and ethical rights, of which these are the most important. It is in your best interests to eradicate every detail of our relationship, and apologize to those whose human and ethical rights you corrupted. You did not have the right to corrupt my innovation, stigmatize me, and corrupt my human and ethical rights..

I advise you to terminate all of your internet activities, and never use it again to disseminate your opinions, positive or negative, about any health related issue. Many physicians are deeply concerned about rampant medical corruption on the internet, of which this is a prime example. 

He's banned me from the internet! Glad to hear I am so effective. If only.

Labels: , ,

Friday, 25 March 2011


Ipilimumab gets FDA approval

...and becomes known as Yervoy...

Wednesday, 23 March 2011


Rigvir- she couldn't let it lie

Inga the Rigvir publicist has been kind enough to write again:

Well, this obviously is a one-man-show. Seanty – the utmost expert in all cancer medicines, and a professional guide to Latvia's medical system. :) The one and only voice of truth from the depths of civilization.

You place a link to a U.S. Clinical Trials website. Why?! What does this link have to do with a medicine which is registered in Latvia?! You won't find RIGVIR in the U.S., Turkey's, Ukraine's, or any other country's clinical trials' sites, and you don't have to spend your precious time trying to prove it. RIGVIR went through all clinical trials in L A T V I A.

By the way, what is this disdain towards my country? Sounds like you're having some personal issues which have nothing to do with objective evaluation of RIGVIR. What next? You will try to force that everyone should eat at McDonald's just because it's the American way?

I will not involve in this again so enjoy your incompetent babbling about civilization, highly infectious viruses, medical systems, clinical trials, untested virotherapy(?!) and so on and so forth.
She also put three links to her employer's quack promotion sites at the end, presumably in the hope that I would be stupid enough to post them up. Duh.

But she has questions: so let's answer them: Why did I post a link to the US clinical trials site, showing no mention of Rigvir? Because if you want to sell a medical treatment worldwide, you register your trial there-but it's not just that Rigvir hasn't been tested to international standards. I can see no evidence that Rigvir has ever been subjected to any clinical trials at all, in Latvia or elsewhere. The dross they list on their publicity site is not reports of clinical trials against melanoma or anything else, or even papers in peer-reviewed scientific journals. It constitutes far more trivial claims, which were never checked by third parties, made twenty years ago.

So, it is untested. It is a virotherapy. It is an untested virotherapy. Fact.

Rigvir is an ECHO virus,  so the claim that it is of  a type which is both highly infectious and responsible for many cases of childhood meningitis is factual.

Why the disdain toward Latvia? Well, joking aside, it's quite a focussed disdain. If Inga and her employers are not in prison, Latvia's medical standards need tightening up.

Labels: , , ,

Monday, 21 March 2011


Story updates

There are updates to Sarah's and Glen's stories of living with Stage 4 MM.

I mention staging because if you put "Stage 4 melanoma" into Google back when I was diagnosed, you were swamped by pages of paid ads and testimonials for quack "cures". Now the first ten pages are lists of clinically proven treatments. If you want a sign of how things have moved on, there it is.

Labels: , ,

Thursday, 17 March 2011


Ipi set for FDA approval

Ipilimumab is strongly rumoured to be on the brink of FDA approval on the back of its successful clinical trials.

Sunday, 13 March 2011


Rigvir again

In Latvia, you can buy lab-modified highly infectious childhood meningitis viruses over the counter in the chemist (and for all I know, the newsagent) with unsubstantiated claims of effectiveness against melanoma. This product, untested for safety or effectiveness, is called Rigvir. "Inga" writes (probably from the office of Rigvir's publicists):

"Sorry if I'm wrong, Seanty, but you are trying so hard to “destroy” Rigvir that it makes me think you have been paid by someone to do so. I wonder who might that have been. Oncovex?"

Be sorry then, Inga, because you are wrong on all counts.

"Nevertheless, it's great you post your opinion, but why do you slender the facts? Let's see - Rigvir has been registered in a member state of the EU, that's a fact. This fact proves that Rigvir has gone through ALL 3 PHASES of clinical trials. Cancer patients should be allowed to decide for themselves on the efficiency of some medicine, but they should not be given wrong information, agree?"

First let's remove the wrong information from your own communication, Inga - Rigvir has not been subjected to a phase 1 clinical trial, let alone passed all three. Latvia's medical system is (to put it politely) not quite as formal as those in the more developed EU countries. That you can buy an untested virotherapy over the counter in pharmacies tells you everything you need to know about medical regulatory standards in Latvia. If it passes clinical trials, Oncovex is not going to be found next to the tampons in Superdrug.

Then there is the question you raise of whether of cancer patients should judge for themselves on the efficiency of cancer medicines. Though I understand you have your own ways on Latvia, over here in civilisation we have doctors for that. It's quite tricky you see, even if you aren't making the decision under threat of death.

A quick look around the internet shows the results of letting frightened unqualified people choose their own treatment for life-threatening illnesses. They get ripped off by bloodsucking scum like your employer, then they die. Other than that it's a great idea, obviously.

Labels: , , ,


Sentinel Node Biopsy

A negative SNB is associated with a very low risk of recurrence in the lymph nodes according to a big new meta analysis.


Friday, 4 March 2011


Melanoma Education Symposium

I've been asked to publicise the Melanoma Education Symposium taking place in Santa Monica on 26th March. I'd go but it's a bit out of my way...


August 2008   September 2008   October 2008   November 2008   December 2008   January 2009   February 2009   April 2009   May 2009   June 2009   July 2009   August 2009   September 2009   October 2009   November 2009   December 2009   January 2010   February 2010   March 2010   April 2010   May 2010   June 2010   July 2010   August 2010   September 2010   October 2010   November 2010   December 2010   February 2011   March 2011   April 2011   May 2011   June 2011   July 2011   August 2011   September 2011   October 2011   November 2011   December 2011   January 2012   February 2012   March 2012   April 2012   May 2012   June 2012   July 2012   September 2012   November 2012   December 2012   January 2013   May 2013   June 2013   July 2013   August 2013   September 2013   October 2013   December 2013   July 2014   May 2015   July 2015  

This page is powered by Blogger. Isn't yours?

Subscribe to Posts [Atom]